6533b870fe1ef96bd12d06e6
RESEARCH PRODUCT
Trace elements in glucometabolic disorders: an update.
Jean-robert RapinNicolas Wiernspergersubject
Endocrinology Diabetes and Metabolism030209 endocrinology & metabolismReviewBioinformatics03 medical and health sciences0302 clinical medicineInsulin resistancemedicineInternal Medicine[SDV.BBM] Life Sciences [q-bio]/Biochemistry Molecular BiologySDV:BBMBiochemical reactionsGlucose homeostasisIn patient[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyBeneficial effects[ SDV.BBM ] Life Sciences [q-bio]/Biochemistry Molecular Biologylcsh:RC620-627030304 developmental biology0303 health sciencesbusiness.industrymedicine.disease3. Good healthTrace (semiology)lcsh:Nutritional diseases. Deficiency diseasesbusinessdescription
International audience; Many trace elements, among which metals, are indispensable for proper functioning of a myriad of biochemical reactions, more particularly as enzyme cofactors. This is particularly true for the vast set of processes involved in regulation of glucose homeostasis, being it in glucose metabolism itself or in hormonal control, especially insulin. The role and importance of trace elements such as chromium, zinc, selenium, lithium and vanadium are much less evident and subjected to chronic debate. This review updates our actual knowledge concerning these five trace elements. A careful survey of the literature shows that while theoretical postulates from some key roles of these elements had led to real hopes for therapy of insulin resistance and diabetes, the limited experience based on available data indicates that beneficial effects and use of most of them are subjected to caution, given the narrow window between safe and unsafe doses. Clear therapeutic benefit in these pathologies is presently doubtful but some data indicate that these metals may have a clinical interest in patients presenting deficiencies in individual metal levels. The same holds true for an association of some trace elements such as chromium or zinc with oral antidiabetics. However, this area is essentially unexplored in adequate clinical trials, which are worth being performed.
year | journal | country | edition | language |
---|---|---|---|---|
2010-12-01 |